Page 656 - Small Animal Internal Medicine, 6th Edition
P. 656

628    PART IV   Hepatobiliary and Exocrine Pancreatic Disorders


            use of such drugs in them might actually worsen the prog-  because it contributes to necrosis. Replacement fluids (e.g.,
            nosis by increasing the risk of gastric ulceration and reduc-  lactated Ringer’s or Plasmalyte) are usually used at rates and
  VetBooks.ir  ing the activity of the reticuloendothelial system in the   volumes that depend on the degree of dehydration and
                                                                 shock—twice the maintenance rates (100-120 mL/kg/day)
            removal of circulating  α 2 -macroglobulin–protease com-
            plexes. In some cases, a dog or cat might need corticosteroid
                                                                 0 and 1), but more severely affected animals may need initial
            therapy for a concurrent condition, such as immune-  are adequate for mild to moderately affected animals (grades
            mediated hemolytic anemia or inflammatory bowel disease,   shock rates (90 mL/kg/h for 30-60 minutes) followed by syn-
            in which case the benefits of corticosteroids may outweigh   thetic colloids. It is important to measure urine output con-
            their potential deleterious effects.                 currently. Rapid crystalloid infusion in severely affected
              Severe, necrotizing pancreatitis carries a poor to very   animals that have a pathologic increase in vascular perme-
            poor prognosis in cats and dogs. These patients have severe   ability carries an increased risk of pulmonary edema, so
            fluid and electrolyte abnormalities associated with systemic   patients should be closely monitored; central venous pres-
            inflammatory disease, renal compromise, and a high risk of   sure ideally should be measured in the most severely affected
            DIC. Intensive management is required, including plasma   dogs and the fluid rate adjusted accordingly to maintain
            transfusions in many cases and enteral tube feeding or total   normal central venous pressure.
            parenteral nutrition (TPN) in some (see next section). These   Serum electrolyte concentrations should be carefully
            patients will likely benefit from referral to a specialist. If   monitored. Potential electrolyte abnormalities are outlined
            referral is not an option, intensive therapy can be attempted   in Table 34.3, but the most clinically relevant is hypokalemia
            in the practice, but the owner must be warned of the very   caused by vomiting and reduced food intake. Hypokalemia
            poor prognosis and expense of treatment. Severe acute pan-  can significantly impair recovery and contribute to mortality
            creatitis also carries a poor prognosis in humans, but the   because it causes not only skeletal muscle weakness but also
            mortality has been reduced in the last 5 years by a combina-  gastrointestinal atony, which will contribute to the clinical
            tion  of  early  and  aggressive  IV  fluid  therapy  and  early   signs of the disease and delay successful feeding. Aggressive
            feeding.                                             fluid therapy further increases renal potassium loss, particu-
              At the other end of the spectrum, patients with very mild   larly in cats, so it is important to measure serum potassium
            pancreatitis may simply need hospitalization for 12 to 24   concentrations  frequently  (at  least  daily  while  the  patient
            hours of IV fluid therapy if they are vomiting and dehy-  is vomiting) and add supplemental potassium chloride to
            drated; if they are alert and well hydrated, they may be   the fluids as necessary. A scaled approach is best, based on
            managed at home with 24 to 48 hours of pancreatic rest   the degree of hypokalemia. Lactated Ringer’s or Plasmalyte
            (fluids only by mouth) and analgesia, followed by long-term   contains only 4 mEq/L potassium, and most cases require
            feeding of an appropriate diet.                      supplementing  at  least  to  replacement  rates  (20 mEq/L).
              It is important to give consideration to the following   Even if the serum potassium concentration cannot be mea-
            aspects of treatment in all patients: IV fluid and electrolyte   sured, a vomiting anorexic dog with no evidence of renal
            replacement; analgesia; nutrition; and other supportive   failure should receive replacement rates of potassium in
            therapy, as indicated, such as antiemetics and antibiotics (see   the fluids. More severely hypokalemic dogs should be sup-
            Box 37.1).                                           plemented more as long as serum concentrations can be
                                                                 measured regularly and infusion rates carefully controlled.
            Intravenous fluids and electrolytes                  A dog or cat with a serum potassium concentration of
            IV fluid therapy is very important in all but the mildest cases   2.0 mEq/L or less should receive between 40 and 60 mEq/L
            of  pancreatitis  to  reverse  dehydration,  address  electrolyte   in the fluids at a controlled infusion rate. As a general rule,
            imbalances associated with vomiting and fluid pooling in the   the infusion rate of potassium should still not be increased
            hypomotile gastrointestinal tract, maintain adequate pancre-  above 0.5 mEq/kg/h.
            atic circulation, and maintain effective peripheral circulation   A plasma transfusion is likely indicated in dogs and cats
            in the presence of the associated SIR. It is vital to prevent   with severe pancreatitis to replace  α 1 -antitrypsin and  α 2 -
            pancreatic ischemia associated with reduced perfusion   macroglobulin. It also supplies clotting factors and may be
                                                                 combined with heparin therapy in animals at high risk of
                                                                 DIC, although the efficacy of heparin therapy in DIC in
                   BOX 37.1                                      humans and animals has been questioned, and there are cur-
                                                                 rently no controlled trials that either support or refute its use
            Pillars of Treatment in Severe Acute Pancreatitis (see text   for pancreatitis in dogs and cats (see Chapter 87).
            for more details)
                                                                 Analgesia
             •  Early, aggressive intravenous fluid therapy (monitor
               urine output and electrolytes)                    Pancreatitis is usually a very painful condition. Hospital-
             •  Analgesia (early and effective—assume pain unless   ized patients should be monitored carefully for pain, and
               proven otherwise)                                 analgesia should be administered as necessary. In practice,
             •  Early enteral feeding (as soon as rehydrated)    analgesia is indicated for almost all patients with pancreati-
                                                                 tis and should be given routinely to cats with pancreatitis
   651   652   653   654   655   656   657   658   659   660   661